...
首页> 外文期刊>The Journal of Nuclear Medicine >Imaging the Enzyme 11 beta-Hydroxysteroid Dehydrogenase Type 1 with PET: Evaluation of the Novel Radiotracer C-11-AS2471907 in Human Brain
【24h】

Imaging the Enzyme 11 beta-Hydroxysteroid Dehydrogenase Type 1 with PET: Evaluation of the Novel Radiotracer C-11-AS2471907 in Human Brain

机译:用PET进行成像酶11β-羟类脱氢酶1型1型:对人脑中的新型radiotracer C-11-AS2471907的评价

获取原文
获取原文并翻译 | 示例
           

摘要

The 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) enzyme converts cortisone to cortisol and participates in the regulation of glucocorticoid levels in tissues. 11 beta-HSD1 is expressed in the liver, kidney, adipose tissue, placenta, and brain. 11 beta-HSD1 is a target for treatment of depression, anxiety, posttraumatic stress disorder, and also against age-related cognitive function and memory loss. In this study, we evaluated the radiotracer C-11-AS2471907 (3-(2-chlorophenyl)- 4-(methyl-C-11)-5-[2-[2,4,6-trifluorophenoxy] propan2- yl]-4H-1,2,4-triazole) to image 11 beta-HSD1 availability in the human brain with PET. Methods: Fifteen subjects were included in the study. All subjects underwent one 2-h scan after a bolus administration of C-11-AS2471907. Two subjects underwent an additional scan after blockade with the selective and high-affinity 11 beta-HSD1 inhibitor ASP3662 to evaluate C-11-AS2471907 nondisplaceable distribution volume. Five subjects also underwent an additional scan to evaluate the within-day test-retest variability of C-11-AS2471907 volumes of distribution (V-T). Results: C-11-AS2471907 time-activity curves were best fitted by the 2-tissue-compartment (2TC) model. C-11-AS2471907 exhibited a regionally varying pattern of uptake throughout the brain. The V-T of C-11-AS2471907 ranged from 3.7 +/- 1.5 mL/cm(3) in the caudate nucleus to 14.5 +/- 5.3 mL/cm(3) in the occipital cortex, with intermediate values in the amygdala, white matter, cingulum, insula, frontal cortex, putamen, temporal and parietal cortices, cerebellum, and thalamus (from lowest to highest V-T). From the blocking scans, nondisplaceable distribution volume was determined to be 0.16 +/- 0.04 mL/cm(3) for C-11-AS2471907. Thus, nearly all uptake was specific and the binding potential ranged from 22 in the caudate to 90 in the occipital cortex. Test-retest variability of 2TC V-T values was less than 10% in most large cortical regions (14% in parietal cortex) and ranged from 14% (cerebellum) to 51% (amygdala) in other regions. The intraclass correlation coefficient of 2TC V-T values ranged from 0.55 in the white matter to 0.98 in the cerebellum. Conclusion: C-11-AS2471907 has a high fraction of specific binding in vivo in humans and reasonable within-day reproducibility of binding parameters.
机译:11β-羟类脱氢酶1(11β-HSD1)酶转化为皮质醇转化为皮质醇,并参与组织中糖皮质激素水平的调节。 11β-HSD1在肝脏,肾,脂肪组织,胎盘和脑中表达。 11 Beta-HSD1是治疗抑郁症,焦虑,错误胁迫障碍的靶点,以及与年龄相关的认知功能和记忆丧失。在这项研究中,我们评估了routiotracer C-11-AS2471907(3-(2-氯苯基) - 4-(甲基-C-11)-5- [2- [2,4,6-三氟氟氧基] Propan2-Y1] -4h-1,2,4-三唑)用宠物的人类大脑的图像11 beta-hsd1可用性。方法:在研究中包含十五个受试者。所有受试者在施用C-11-AS2471907的施用后,所有受试者都在一次2-H扫描。两个受试者在用选择性和高亲和力11β-HSD1抑制剂ASP3662延迟封锁后进行额外的扫描,以评估C-11-AS2471907无处可行分布体积。五个受试者还经历了额外的扫描,以评估C-11-AS2471907分布(V-T)的日期测试标准变异性。结果:C-11-AS2471907由2组织隔室(2TC)模型最适合安装时间活动曲线。 C-11-AS2471907在整个大脑中表现出区域不同的摄取模式。 C-11-AS2471907的vt在芯片皮层中的3.7 +/- 1.5ml / cm(3)范围为14.5 +/- 5.3ml / cm(3),在Amygdala,白色的中间值物质,Cingulum,Insula,额叶,腐烂,颞骨和椎管皮质皮质,小脑和丘脑(从最低到最高VT)。从阻断扫描,对于C-11-AS2471907,确定不可避可分布体积为0.16 +/- 0.04ml / cm(3)。因此,几乎所有摄取都是特异性的,并且在枕骨皮质中的尾部中的22中的结合电位范围为22。在大多数大型皮质区域(位于皮质皮层14%)中,2TC V-T值的测试重度变异性小于10%,并在其他地区的14%(小脑)至51%(Amygdala)范围内。 2TC V-T值的腹积相关系数在白物中的0.55范围为0.55,在小脑中为0.98。结论:C-11-AS2471907在人类体内具有高分子特异性结合,合理的结合参数的日期内可再现性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号